• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

Analysts: Pfizer's Run is Done as 2 funds dump all Pfizer stock!

Anonymous

Guest
Pfizer's Run Might be Done.

http://blogs.barrons.com/stockstowatchtoday/2011/11/14/pfizers-run-might-be-done-leerink-swank/

Sell! Sell! Sell!

Hedge fund Greenlight Capital Inc. disclosed Monday that it exited all holdings like drug company Pfizer Inc, of which it previously held 23.5 million shares.

David Tepper’s Appaloosa investment fund apparently has sold its entire holdings of its largest stock position, in Pfizer. A quarterly snapshot of Appaloosa’s investment holdings showed no ownership of Pfizer stock as of Sept. 30. The months earlier, the firm owned 14.5 million shares of Pfizer. The firm completely eliminated its stakes in Pfizer Inc., which had been one of its largest holdings by value, a stake worth nearly $300 million as of June 30.
 
















Investors probably feel so burned by the horrible underperformance of Pfizer stock for the last 5-8 years that they no longer want it to tarnish their portfolios! Wise money managers say to sell underperforming funds now and take your losses, I believe their may be a tax incentive if it's done before year's end.